Maissa El Raziky

Changes in liver stiffness measurements and fibrosis scores following sofosbuvir based treatment regimens without interferon

Aisha Elsharkawy, Shereen Abdel Alem, Rabab Fouad et al. · Journal of Gastroenterology and Hepatology · 2017 · 91 citations

Planning and prioritizing direct-acting antivirals treatment for HCV patients in countries with limited resources: Lessons from the Egyptian experience

Aisha Elsharkawy, Maissa El Raziky, Wafaa Elakel et al. · Journal of Hepatology · 2017 · 73 citations

Hcv Patients, Direct-acting Antivirals Treatment, Egyptian Experience +10

Sofosbuvir‐based treatment regimens: real life results of 14 409 chronic <scp>HCV</scp> genotype 4 patients in Egypt

A. Elsharkawy, Rabab Fouad, Wafaa Elakel et al. · Alimentary Pharmacology & Therapeutics · 2017 · 72 citations · Full text

Real life Egyptian experience of efficacy and safety of Simeprevir/Sofosbuvir therapy in 6211 chronic <scp>HCV</scp> genotype <scp>IV</scp> infected patients

Rasha Eletreby, Wafaa Elakel, Mohamed Said et al. · Liver International · 2016 · 60 citations

Evaluation of serum biomarkers of fibrosis and injury in Egyptian patients with chronic hepatitis C

Gamal Esmat, Mohamed A. Metwally, Khalid Zalata et al. · Journal of Hepatology · 2007 · 53 citations

Hepatology, Hepatitis C, Viral Hepatitis +13